Class S autoclaves market seen topping $1.9 billion by 2030

The class S autoclaves market is projected to grow from $1.16 billion in 2025 to $1.28 billion in 2026, then reach $1.9 billion by 2030, driven by more surgeries, tighter sterilization rules and expanding healthcare infrastructure. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Class S autoclaves are becoming more important as healthcare and laboratory users need tighter control over sterilization and infection prevention. - The market’s projected growth signals stronger demand for advanced sterilization equipment across hospitals, dental care, pharmaceutical production, veterinary clinics and research facilities.

What happened: - The Business Research Company released its Class S Autoclaves Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report pegs the market at $1.16 billion in 2025 and $1.28 billion in 2026. - The market is forecast to reach $1.9 billion by 2030. - North America was the largest regional market in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period.

The details: - The 2026 growth estimate implies a 10.7% CAGR. - The 2026-2030 forecast implies a 10.4% CAGR. - Growth drivers include new hospital construction, rising demand for dental care, pharmaceutical production growth, stricter sterilization regulations and wider adoption of tabletop autoclaves in laboratories. - Class S autoclaves are designed to sterilize specific medical and laboratory tools that need tightly controlled temperature, pressure and steam exposure. - The devices are built to eliminate microorganisms and support instrument safety. - The report says the systems comply with established safety and efficacy standards. - The report’s regional coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - A free sample and full report are available through the company’s announcement: Download a free sample and View the full market report.

Between the lines: - The strongest demand signal comes from higher surgical volumes, which require reliable sterilization to keep operating environments sterile. - ISAPS data from June 2024 showed liposuction remained the most frequently performed surgical procedure in both 2022 and 2023. - Plastic surgeons performed 5.5% more surgeries in 2023, exceeding 15.8 million procedures. - The report’s emphasis on automation, remote monitoring and energy-saving cycles suggests buyers are prioritizing efficiency as well as compliance. - Digital monitoring and IoT-enabled systems point to a shift toward connected sterilization workflows in larger clinical settings.

What's next: - Demand is likely to keep rising as healthcare infrastructure expands in emerging economies. - Ongoing technology upgrades are expected to push adoption of digital monitoring, hospital management system integration and remote tracking features. - The report also points to more use in veterinary clinics and research facilities as the market broadens. - Steam and dry-heat cycle optimization, along with automation, are likely to remain key product themes through 2030.

The bottom line: - Class S autoclaves are moving from niche sterilization tools to a broader infrastructure need as medical procedures rise and healthcare systems demand more efficient, connected sterilization solutions.